Combined iron sucrose and protoporphyrin treatment protects against ischemic and toxin-mediated acute renal failure

Kidney International

Volumn 90, Issue 1, 2016, Pages 67-76

  Zager, Richard A ^a,b   Johnson, Ali C M ^a   Frostad, Kirsten B ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

acute kidney injury; ischemia reperfusion; nephrotoxicity

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 1 MICROGLOBULIN; CREATININE; CYANOCOBALAMIN; GLYCEROL; HAPTOGLOBIN; HEME OXYGENASE 1; HEMOPEXIN; HEPCIDIN; INTERLEUKIN 10; IRON SACCHARATE; MALEIC ACID; MESSENGER RNA; PROTOPORPHYRIN TIN; TOXIN; TROPONIN I; ALPHA GLOBULIN; ALPHA-1-MICROGLOBULIN; FERRIC ION; FERRIC OXIDE, SACCHARATED; IL10 PROTEIN, MOUSE; MALEIC ACID DERIVATIVE; METALLOPORPHYRIN; PROTECTIVE AGENT; PROTOPORPHYRIN; SACCHARIC ACID; TROPONIN C;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GENE CONTROL; GENE EXPRESSION; HEART MUSCLE INJURY; HEART PROTECTION; INJURY SEVERITY; ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RENAL PROTECTION; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; ANIMAL; BLOOD; CHEMICALLY INDUCED; COMBINATION DRUG THERAPY; DISEASE MODEL; KIDNEY; METABOLISM; PATHOLOGY;

ACUTE KIDNEY INJURY; ALPHA 1-ANTITRYPSIN; ALPHA-GLOBULINS; ANIMALS; BLOOD UREA NITROGEN; CREATININE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; FERRIC COMPOUNDS; GLUCARIC ACID; GLYCEROL; HAPTOGLOBINS; HEME OXYGENASE-1; HEMOPEXIN; HEPCIDINS; INTERLEUKIN-10; KIDNEY; MALE; MALEATES; METALLOPORPHYRINS; MICE; PROTECTIVE AGENTS; PROTOPORPHYRINS; RNA, MESSENGER; TROPONIN C;

EID: 84988354702     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.01.022     Document Type: Article

References (37)

1. 1 Ishani, A., Xue, J.L., Himmelfarb, J., et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20 (2009), 223–228.
2. 2 Xue, J.L., Daniels, F., Star, R.A., et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17 (2006), 1135–1142.
3. 3 Liangos, O., Wald, R., O'Bell, J.W., et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 1 (2006), 43–51.
4. 4 Wald, R., Quinn, R.R., Luo, J., et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302 (2009), 1179–1185.
5. 5 Goldberg, A., Kogan, E., Hammerman, H., et al. The impact of transient and persistent acute kidney injury on long-term outcomes after acute myocardial infarction. Kidney Int 76 (2009), 900–906.
6. 6 Chertow, G.M., Burdick, E., Honour, M., et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16 (2005), 3365–3370.
7. 7 Lo, L.J., Go, A.S., Chertow, G.M., et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76 (2009), 893–999.
8. 8 Zager, R.A., Marked protection against acute renal and hepatic injury after nitrited myoglobin + tin protoporphyrin administration. Transl Res 166 (2015), 485–501.
9. 9 Hill-Kapturczak, N., Jarmi, T., Agarwal, A., Growth factors and heme oxygenase-1: perspectives in physiology and pathophysiology. Antioxid Redox Signal 9 (2007), 2197–2207.
10. 10 Nath, K.A., Balla, G., Vercellotti, G.M., et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 90 (1992), 267–270.
11. 11 Agarwal, A., Bolisetty, S., Adaptive responses to tissue injury: role of heme oxygenase-1. Trans Am Clin Climatol Assoc 124 (2013), 111–122.
12. 12 Rassaf, T., Totzeck, M., Hendgen-Cotta, U.B., et al. Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circ Res 114 (2014), 1601–1610.
13. 13 Totzeck, M., Hendgen-Cotta, U.B., Luedike, P., Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation. Circulation 126 (2012), 325–334.
14. 14 Goyal, A., Semwal, B.C., Yadav, H.N., Abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart. [e-pub ahead of print] Hum Exp Toxicol, 11 August 2015, 10.1177/0960327115597980.
15. 15 Hendgen-Cotta, U.B., Merx, M.W., Shiva, S., et al. Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc Natl Acad Sci U S A 105 (2008), 10256–10261.
16. 16 Sardana, M.K., Kappas, A., Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc Natl Acad Sci U S A 84 (1987), 2464–2468.
17. 17 Kellerman, P.S., Exogenous adenosine triphosphate (ATP) preserves proximal tubule microfilament structure and function in vivo in a maleic acid model of ATP depletion. J Clin Invest 92 (1993), 1940–1949.
18. 18 Zager, R.A., Johnson, A.C., Naito, M., Bomsztyk, K., Maleate nephrotoxicity: mechanisms of injury and correlates with ischemic/hypoxic tubular cell death. Am J Physiol 294 (2008), F187–F197.
19. 19 Zager, R.A., Johnson, A.C., Becker, K., Plasma and urinary heme oxygenase-1 in AKI. J Am Soc Nephrol 23 (2012), 1048–1057.
20. 20 Zager, R.A., Johnson, A.C., Hanson, S.Y., Wasse, H., Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. Am J Kidney Dis 40 (2002), 90–103.
21. 21 Johnson, A.C., Becker, K., Zager, R.A., Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury. Am J Physiol Renal Physiol 299 (2010), F426–F435.
22. 22 Zager, R.A., Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease. Clin J Am Soc Nephrol(suppl 1), 2006, S24–S31.
23. 23 Zager, R.A., Johnson, A.C., Frostad, K.B., Rapid renal alpha-1 antitrypsin gene induction in experimental and clinical acute kidney injury. PLoS One, 9, 2014, e9838.
24. 24 Zager, R.A., Johnson, A.C., Becker, K., Renal cortical hemopexin accumulation in response to acute kidney injury. Am J Physiol 303 (2012), F1460–F1472.
25. 25 Åkerström, B., Gram, M., A1M, an extravascular tissue cleaning and housekeeping protein. Free Radic Biol Med 74 (2014), 274–282.
26. 26 Scindia, Y., Dey, P., Thirunagari, A., et al. Hepcidin mitigates renal ischemia-reperfusion injury by modulating systemic iron homeostasis. J Am Soc Nephrol 26 (2015), 2800–2814.
27. 27 Blumenthal, S.B., Kiemer, A.K., Tiegs, G., et al. Metalloporphyrins inactivate caspase-3 and -8. FASEB J 19 (2005), 1272–1279.
28. 28 Kaizu, T., Tamaki, T., Tanaka, M., et al. Preconditioning with tin-protoporphyrin IX attenuates ischemia/reperfusion injury in the rat kidney. Kidney Int 63 (2003), 1393–1403.
29. 29 Issan, Y., Kornowski, R., Aravot, D., et al. Heme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stress. PLoS One, 9, 2014, e92246.
30. 30 Virzì, G.M., Day, S., de Cal, M., et al. Heart-kidney crosstalk and role of humoral signaling in critical illness. Crit Care, 18, 2014, 201.
31. 31 Li, X., Hassoun, H.T., Santora, R., Rabb, H., Organ crosstalk: the role of the kidney. Curr Opin Crit Care 5 (2009), 481–487.
32. 32 Grams, M.E., Rabb, H., The distant organ effects of acute kidney injury. Kidney Int 81 (2012), 942–948.
33. 33 Kappas, A., Drummond, G.S., Manola, T., et al. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility. Pediatrics 81 (1988), 485–497.
34. 34 Reddy, P., Najundaswamy, S., Mehta, R., et al. Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant. J Perinatol 23 (2003), 507–512.
35. 35 Zager, R.A., Vijayan, A., Johnson, A.C., Proximal tubule haptoglobin gene activation is an integral component of the acute kidney injury “stress response.”. Am J Physiol 303 (2012), F139–F148.
36. 36 Zager, R.A., Johnson, A.C., Frostad, K.B., Acute hepatic ischemic-reperfusion injury induces a renal cortical “stress response,” renal “cytoresistance,” and an endotoxin hyperresponsive state. Am J Physiol Renal Physiol 307 (2014), F856–F868.
37. 37 Klemz, R., Mashreghi, M.F., Spies, C., et al. Amplifying the fluorescence of bilirubin enables the real-time detection of heme oxygenase activity. Free Radic Biol Med 42 (2009), 305–311.